TY - JOUR
T1 - Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8+ T lymphocyte emergence
AU - Benlalam, Houssem
AU - Carré, Thibault
AU - Jalil, Abdelali
AU - Noman, Zaeem
AU - Caillou, Bernard
AU - Vielh, Philippe
AU - Tittarelli, Andrés
AU - Robert, Caroline
AU - Chouaib, Salem
PY - 2013/10/1
Y1 - 2013/10/1
N2 - Gap junctions (GJs) enable intercellular communication between adjacent cells through channels of connexins. Using a three-dimensional construct, we previously showed that endothelial and tumor cells formed GJs, allowing melanoma-specific T lymphocytes to recognize and kill melanoma-derived endothelial cells. We demonstrate here on histological sections of melanoma biopsies that GJ formation occurs in vivo between tumor and endothelial cells and between T lymphocytes and target cells. We also show an in vitro increase of GJ formation in melanoma and endothelial cells following dacarbazin and interferon gamma (IFN-γ) treatment or hypoxic stress induction. Our data indicate that although connexin 43 (Cx43), the main GJ protein of the immune system, was localized at the immunological synapse between T lymphocyte and autologous melanoma cells, its over-expression or inhibition of GJs does not interfere with cytotoxic T lymphocyte (CTL) clone lytic function. In contrast, we showed that inhibition of GJs by oleamide during stimulation of resting PBMCs with Melan-A natural and analog peptides resulted in a decrease in antigen (Ag) specific CD8+ T lymphocyte induction. These Ag-specific CD8 + cells displayed paradoxically stronger reactivity as revealed by CD107a degranulation and IFN-γ secretion. These findings indicate that Cx43 does not affect lytic function of differentiated CTL, but reveal a major role for GJs in the regulation of antigen CD8+-naïve T lymphocyte activation. Key message: GJ formation occurs in vivo between T lymphocytes and tumor cells Cx43 localized at the immunological synapse between T and autologous melanoma cells Inhibition of GJs resulted in a decrease in Ag-specific CD8+ T lymphocyte induction A role for GJs in the regulation of antigen CD8+-naïve T lymphocyte activation
AB - Gap junctions (GJs) enable intercellular communication between adjacent cells through channels of connexins. Using a three-dimensional construct, we previously showed that endothelial and tumor cells formed GJs, allowing melanoma-specific T lymphocytes to recognize and kill melanoma-derived endothelial cells. We demonstrate here on histological sections of melanoma biopsies that GJ formation occurs in vivo between tumor and endothelial cells and between T lymphocytes and target cells. We also show an in vitro increase of GJ formation in melanoma and endothelial cells following dacarbazin and interferon gamma (IFN-γ) treatment or hypoxic stress induction. Our data indicate that although connexin 43 (Cx43), the main GJ protein of the immune system, was localized at the immunological synapse between T lymphocyte and autologous melanoma cells, its over-expression or inhibition of GJs does not interfere with cytotoxic T lymphocyte (CTL) clone lytic function. In contrast, we showed that inhibition of GJs by oleamide during stimulation of resting PBMCs with Melan-A natural and analog peptides resulted in a decrease in antigen (Ag) specific CD8+ T lymphocyte induction. These Ag-specific CD8 + cells displayed paradoxically stronger reactivity as revealed by CD107a degranulation and IFN-γ secretion. These findings indicate that Cx43 does not affect lytic function of differentiated CTL, but reveal a major role for GJs in the regulation of antigen CD8+-naïve T lymphocyte activation. Key message: GJ formation occurs in vivo between T lymphocytes and tumor cells Cx43 localized at the immunological synapse between T and autologous melanoma cells Inhibition of GJs resulted in a decrease in Ag-specific CD8+ T lymphocyte induction A role for GJs in the regulation of antigen CD8+-naïve T lymphocyte activation
KW - Antigen presentation
KW - Connexin 43
KW - Cytotoxic T cell
KW - Gap junction
KW - Melanoma
UR - http://www.scopus.com/inward/record.url?scp=84885306468&partnerID=8YFLogxK
U2 - 10.1007/s00109-013-1058-5
DO - 10.1007/s00109-013-1058-5
M3 - Article
C2 - 23744108
AN - SCOPUS:84885306468
SN - 0946-2716
VL - 91
SP - 1207
EP - 1220
JO - Journal of Molecular Medicine
JF - Journal of Molecular Medicine
IS - 10
ER -